Supplementary Figure 5. Treatment with BRAF inhibitor is enough to prolong RAS/ERK signaling pathway blockage in PMP models.
No takes yet. Share an insight, caveat, or question.
Martínez‐Quintanilla et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: